217 related articles for article (PubMed ID: 26484928)
21. Alzheimer's disease: are blood and brain markers related? A systematic review.
Khan AT; Dobson RJ; Sattlecker M; Kiddle SJ
Ann Clin Transl Neurol; 2016 Jun; 3(6):455-62. PubMed ID: 27547773
[TBL] [Abstract][Full Text] [Related]
22. MiRNAs of peripheral blood as the biomarker of schizophrenia.
He K; Guo C; He L; Shi Y
Hereditas; 2018; 155():9. PubMed ID: 28860957
[TBL] [Abstract][Full Text] [Related]
23. Potential Application of MicroRNAs and Some Other Molecular Biomarkers in Alzheimer's Disease.
Paprzycka O; Wieczorek J; Nowak I; Madej M; Strzalka-Mrozik B
Curr Issues Mol Biol; 2024 May; 46(6):5066-5084. PubMed ID: 38920976
[TBL] [Abstract][Full Text] [Related]
24. Blood-Based Biomarkers for Glioma in the Context of Gliomagenesis: A Systematic Review.
Ali H; Harting R; de Vries R; Ali M; Wurdinger T; Best MG
Front Oncol; 2021; 11():665235. PubMed ID: 34150629
[TBL] [Abstract][Full Text] [Related]
25. A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations.
Kiddle SJ; Voyle N; Dobson RJB
J Alzheimers Dis; 2018; 64(s1):S289-S297. PubMed ID: 29614671
[TBL] [Abstract][Full Text] [Related]
26. An Integrative Review about Electrophysiological Biomarkers of Cognitive Impairment in Alzheimer's Disease: A Developing Relationship.
Holston EC
Issues Ment Health Nurs; 2024 Jul; ():1-12. PubMed ID: 38954497
[No Abstract] [Full Text] [Related]
27. The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD.
Fessel J
Alzheimers Dement (N Y); 2020; 6(1):e12003. PubMed ID: 32258360
[TBL] [Abstract][Full Text] [Related]
28. Searching for New Biomarkers in Respiratory Medicine: Present and Future of miRNAs.
Dodani K; de Gonzalo-Calvo D; Sánchez-de-la-Torre M
Arch Bronconeumol; 2024 Mar; 60(3):125-128. PubMed ID: 37932213
[No Abstract] [Full Text] [Related]
29. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
Riancho J; Vázquez-Higuera JL; Pozueta A; Lage C; Kazimierczak M; Bravo M; Calero M; Gonalezález A; Rodríguez E; Lleó A; Sánchez-Juan P
J Alzheimers Dis; 2017; 57(2):483-491. PubMed ID: 28269782
[TBL] [Abstract][Full Text] [Related]
30. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
Kumar S; Reddy PH
Biochim Biophys Acta; 2016 Sep; 1862(9):1617-27. PubMed ID: 27264337
[TBL] [Abstract][Full Text] [Related]
31. miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease.
Mushtaq G; Greig NH; Anwar F; Zamzami MA; Choudhry H; Shaik MM; Tamargo IA; Kamal MA
Med Chem; 2016; 12(3):217-25. PubMed ID: 26527155
[TBL] [Abstract][Full Text] [Related]
32. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease.
Van Giau V; An SS
J Neurol Sci; 2016 Jan; 360():141-52. PubMed ID: 26723991
[TBL] [Abstract][Full Text] [Related]
33. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
Gui Y; Liu H; Zhang L; Lv W; Hu X
Oncotarget; 2015 Nov; 6(35):37043-53. PubMed ID: 26497684
[TBL] [Abstract][Full Text] [Related]
34. Peripheral Blood MicroRNA Expression Profiles in Alzheimer's Disease: Screening, Validation, Association with Clinical Phenotype and Implications for Molecular Mechanism.
Ren RJ; Zhang YF; Dammer EB; Zhou Y; Wang LL; Liu XH; Feng BL; Jiang GX; Chen SD; Wang G; Cheng Q
Mol Neurobiol; 2016 Oct; 53(8):5772-81. PubMed ID: 26497032
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
36. microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain.
Kim J; Yoon H; Horie T; Burchett JM; Restivo JL; Rotllan N; Ramírez CM; Verghese PB; Ihara M; Hoe HS; Esau C; Fernández-Hernando C; Holtzman DM; Cirrito JR; Ono K; Kim J
J Neurosci; 2015 Nov; 35(44):14717-26. PubMed ID: 26538644
[TBL] [Abstract][Full Text] [Related]
37. Circulating microRNAs as novel biomarkers of Alzheimer's disease.
Zendjabil M
Clin Chim Acta; 2018 Sep; 484():99-104. PubMed ID: 29800558
[TBL] [Abstract][Full Text] [Related]
38. Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects.
Nagaraj S; Laskowska-Kaszub K; Dębski KJ; Wojsiat J; Dąbrowski M; Gabryelewicz T; Kuźnicki J; Wojda U
Oncotarget; 2017 Mar; 8(10):16122-16143. PubMed ID: 28179587
[TBL] [Abstract][Full Text] [Related]
39. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
40. Circulating microRNAs in Neurodegenerative Diseases.
Grasso M; Piscopo P; Crestini A; Confaloni A; Denti MA
Exp Suppl; 2015; 106():151-169. PubMed ID: 26608203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
